H19 and neoplasm: These findings demonstrate that a normal H19/ICR1 methylation value from a blood sample is insufficient to exclude mosaic 11p15.5 LOI in a patient with BWT, and non-diseased kidney and tumor samples may be required for definitive evaluation.